key: cord-0845819-mfv78gc4 authors: Khan, Nabab title: Possible protective role of 17β-estradiol against COVID-19 date: 2020-08-19 journal: J Allergy Infect Dis DOI: 10.46439/allergy.1.010 sha: 9ccbab14146252ab305278416bb2832a6e708290 doc_id: 845819 cord_uid: mfv78gc4 Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is the virus that causes coronavirus disease 2019 (COVID-19); a worldwide pandemic as declared by the World Health Organization (WHO). SARS-CoV-2 appears to infect cells by first binding and priming its viral-spike proteins with membrane-associated angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2). Through the coordinated actions of ACE2 and TMPRSS2, SARS-CoV-2 spike proteins fuse with plasma membranes and ultimately the virus enters cells. ACE2 is integral to the renin-angiotensin-aldosterone system (RAAS), and SARS-CoV-2 down-regulates protein expression levels of ACE2. Once infected, patients typically develop acute respiratory distress syndrome (ARDS) and a number of other severe complications that result in a high rate of fatality, especially in older (>60 years) adults and in people with pre-existing medical conditions. Data now indicate clearly that among people of all age groups, COVID-19 fatalities are higher in men than women. Here, attention is focused on these sex differences and posit a role of estrogen in these differences as well as possible therapeutic and protective actions of 17β-estradiol against COVID-19. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel virus in the coronaviridae family that causes the disease now termed coronavirus 2019 (COVID-19) [1, 2] . SARS-CoV-2 is a large single-stranded RNA enveloped virus [3] that reportedly originated in China [3] and that has now spread quickly worldwide leaving behind severe medical complications, high levels of fatality, and serious disruptions in normal daily living and global economies [4] . Accordingly, the WHO declared COVID-19 to be a pandemic. SARS-CoV-2 infects cells by binding viral-spike proteins with membrane-associated angiotensin-converting enzyme 2 (ACE2) and priming of spike proteins by transmembrane protease serine 2 (TMPRSS2). Together ACE2 and TMPRSS2 facilitate the entry of SARS-CoV2 into cells by promoting the fusion of viral proteins with host plasma membranes [5, 6] . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. considered to be nuclear steroid receptors, but are in fact associated with plasma membranes, cytoplasm as well as the nucleus. Both ER-α and ER-β are involved in both cellular signaling and the regulation of gene expression through induction of ligandactivated transcription factors and direct binding to promoter-associated estrogen response elements (ERE) of target genes [57] [58] [59] . 17β-estradiol protects against multiple pathological complications including ARDS [60-64], hypertension [65, 66] , atherosclerosis [67] , vasoconstriction [68, 69] , fibrosis [70, 71] , inflammation [72] [73] [74] , autoimmune diseases [75] [76] [77] , viral infections [53, [78] [79] [80] , and neurological disorders [81] [82] [83] . Because of such wideranging effects, it is important to consider the extent to which 17β-estradiol might control SARS-CoV-2 and the expression of this virus's associated disease COVID-19 [84] [85] [86] [87] [88] through its ability to affect the RAAS system, anti-inflammatory and anti-viral responses, and upregulation of endolysosomal degradation pathways. RAAS is a hormone/enzyme system that regulates functions of multiple organs including lungs, heart, brain, vasculature, kidneys, liver, and pancreas [89] . RAAS is composed of the classical ACE/Ang-II/AT1 axis and the non-classical ACE2/ang-(1-7)/Mas axis [90] . The renin-catalyzed conversion of angiotensin to angiotensin-I is followed by the ACE-catalyzed conversion of Ang I to Ang II; Ang II activates the AT1 (Angiotensin II type 1) receptor. The non-classical pathway consists of ACE2, Ang 1-7 (Angiotensin I-7)-Ang II receptor AT2, and the Angiotensin II receptor type 2-Mas axis. The ACE2/ang-(1-7)/Mas axis is a master regulator of the RAAS system; it controls the ACE/Ang-II/AT1R axis [90, 91] . However, when dysfunctional the ACE2/ang-(1-7)/Mas axis can lead to ARDS [16, 17, 92] , hypertension [11, 91, 93] , and inflammation [28,94]. The RAAS system is differentially regulated in a sex-dependent manner [95] [96] [97] . Men have higher expression levels of the ACE/Ang-II/AT1R axis, whereas the ACE2/ang-(1-7)/Mas is more active in women [97, 98] . Indeed, in women, treatment with 17β-estradiol enhanced the ACE2/ang-(1-7)/Mas receptor axis [95, [99] [100] [101] [102] . In contrast, testosterone was less effective than was 17β-estradiol even though testosterone has been shown to downregulate angiotensin II type 2 receptor by androgen-receptor-mediated signaling pathways [95, 99, [103] [104] [105] . Levels of 17β-estradiol decline with age in post-menopausal women [106] and so do activity levels of the 17β-estradiol-controlled ACE2/ang-(1-7)/Mas axis. The consequence of these age-related changes is greater susceptibility to RAAS-related pathologies [105, [107] [108] [109] including ARDS and other acute lung diseases [110, 111] , hypertension [112] , cardiovascular [113] , inflammation [109, 114] , and fibrosis [115] . various factors including lipopolysaccharides, aging, and comorbid conditions like diabetes [11, [121] [122] [123] ; all linked to RAAS. Hence, 17β-estradiol administration could rescue the SARS-CoV-2 infection caused low levels of ACE2 remains to be further investigated. Innate and adaptive immune responses control host-pathogen interactions [124, 125] , and women appear to have more robust immune responses than do men [44, 126] ; for viral infections this may be due to more efficient clearance of viruses [51, 52] . However, robust immune responses in women may also lead to detrimental outcomes [126] [127] [128] . Sex-biased responses to viral infection are dependent on many factors including the presence of disease susceptible genes, different copy numbers of X-linked genes, and sex-dependent steroid hormones [47, 126, [128] [129] [130] . X-linked genes (eg. TLR7) and sex-specific hormones (eg. estrogen and testosterone) can affect adaptive and innate immune responses to pathogens [48] [49] [50] 73, 126, 129] . TLR and NLR (NOD-like receptor) are known as pathogen-recognizing receptors (PRRs), which recognize diverse pathogen-associated molecules patterns (PAMPs) [131] . PRRs are expressed in most cells including T lymphocytes, B-cells, dendritic cells, macrophages, and epithelial cells [131, 132] . Cellular signaling pathways and transcription factors that regulate inflammation and immune responses are activated by PAMPs and PRRs [131, 132] . HIV-1 encoded TLR7 ligands enhance the production of the antiviral factor interferon-α (IFN-α) more robustly in females compared to males [133] . Also, 17β-estradiol enhances the production of TLR-7/9-mediated interferon-α responses in post-menopause women [48, 49, 134] . However, 17β-estradiol can suppress PAMPs' responses and restrict inflammation [135] [136] [137] [138] . Additionally, 17β-estradiol can abrogate NLRP3-mediated airway inflammation in asthma [139] . Levels of 17β-estradiol's are higher in women during reproduction and pre-menopause age [140] , and this correlates with robust innate immune responses and enhanced ability to clear viruses [52, 141] . Lower levels of 17β-estradiol are observed during menopause and this corresponds to decreased immune responses and increased levels of the pro-inflammatory cytokines IL-6, IL-1β, and TNF-α [73, 140] . The involvement of 17β-estradiol in these responses is supported by findings that 17β-estradiol supplementation suppresses the production of pro-inflammatory cytokines and boosts immune responses [47, 73, [142] [143] [144] . In contrast, high testosterone levels can reduce immune responses in response of the influenza vaccine [46, 128] . Women as well as men with lower levels of testosterone both exhibit higher immune responses and more protection against infections [46] . Although different mechanisms are involved, 17β-estradiol suppresses infection of multiple viruses including influenza [51], HCV [80] , Rubella virus [79] , HIV-1 [78, 133] , HSV-1 [141] , and SARS-CoV [54] . Experimentally in mice, greater levels of SARS-CoV infection were found in male mice [54] by a mechanism involving estrogen receptor-associated signaling [54], higher accumulation of inflammatory cells, and increased levels of some specific cytokines [IL-6,TNF-α,IL-1β], and chemokines (CXCL-1, CCL2). SARS-CoV2 induces an inflammatory storm in patients with severe symptoms [145] , and multiple anti-inflammatory strategies are being tested for their ability to suppress virus-induced severe acute respiratory distress syndromes, including tocilizumab and anti-TNF-α therapy. IL-6 and TNF-α both play important roles in inflammatory storms and ARDS development [146, 147] . Tocilizumab, a humanized anti-human IL-6 receptor monoclonal antibody, has been used against COVID-19 and results show improvement in clinical symptoms and suppression of IL-6-mediated inflammation [148, 149] . Similarly, anti-TNF therapies are being tested clinically to protect people at high risk for COVID-19 [149, 150] . The antiinflammatory effects of 17β-estradiol [73, 74, [151] [152] [153] include its ability to decrease ARDS by reducing inflammation and infiltration of immune cells in lungs [154] , suppress LPS and burn trauma-induced acute lung injury [61], and attenuate NF-kB-mediated inflammation [63, 155] . These might help explain results that women have fewer fatalities in COVID-19 and similarly with SARS-CoV and MERS-CoV. Endolysosomes are acidic organelles that participate in the degradation of intracellular and extracellular macromolecules, components of plasma membranes, and cellular fragments [156] [157] [158] [159] . In addition to their role in regulating autophagy, endolysosomes help regulate various cellular processes including membrane resealing, cell death, antigen presentation, cellular trafficking, and cell division [160] [161] [162] [163] [164] . Functional and structural changes to endolysosomes have been implicated in multiple diseases including cancer, neurodegenerative diseases, and infections [165] [166] [167] [168] . Testosterone and 17β-estradiol both affect endolysosomes as well as the process of autophagy [95, [169] [170] [171] [172] [173] . Testosterone upregulates expression levels of androgen-binding protein (ABP) [171] and androgens inhibit autophagy [172, 174] . Moreover, testosterone enhances muscle mass by suppressing autophagy via AMPK inactivation [173] . In contrast, 17β-estradiol upregulates autophagy by diverse mechanisms [169] ; it enhances lysosomal catabolic activity [170] , promotes phagocytosis [175] , and regulates lysosomal activity and autophagy by activating AMPK [169, 176] . AMPK regulates RAAS; it enhances the phosphorylation and stability of ACE2 and controls endothelial homeostasis and pulmonary hypertension [177, 178] . Additionally, the AMPK-p-ACE2 axis is impaired in human lungs with idiopathic pulmonary arterial hypertension (IPAH) [178] . Therefore, in COVID-19 patients, 17β-estradiol through increasing AMPK activity may up-regulate ACE2 and thereby suppress the development of severe symptoms [176, [179] [180] [181] [182] . Viral infection typically requires the involvement of endolysosomes [183, 184] and SARS-CoV-2 is endocytosed following fusion with cell membranes in a pH-dependent manner [5, 185] . Unclear, however, are mechanisms by which endocytosed virus is released from endolysosomes. Regardless, 17β-estradiol may stimulate endolysosomes to promote the degradation of cellular or extracellular materials [186] . Recently, it has been proved that SARS-CoV-2 blocks the autophagy pathway; however, spermidine reduce SARS-COV-2 infection by alleviating the lysosomal degradation pathway [187] . Hence, it needs to validate further that 17β-estradiol may restrict the SARS-CoV-2 infection by promoting the endolysosomal degradation pathway? SARS-CoV-2 infects men and women at the same rate, but men have a higher risk of developing severe complications and death. SARS-CoV-2 infects men and women at the same rate, but men have a higher risk of developing severe complications and death. Immune-compromised patients with hypertension, diabetes, cancer, and HIV-1 are at higher risk of being infected with the virus and developing severe symptoms including ARDS and death. 17β-estradiol might decrease SARS-CoV-2 infection by controlling RAAS, suppressing inflammatory storms, inducing anti-viral immune responses, and enhancing the virus' degradation in endolysosomes by promoting the fusion of endosomes and lysosomes. High-risk patients may benefit from strategies designed to increase levels of 17β-estradiol by consuming estrogen pills and 17β-estradiol-enriched herbs [188, 189] . Finally, it is important to address albeit briefly why postmenopausal women who have low levels of estradiol are still exhibiting lower death rates than are men from COVID-19. One reason might be the presence of catalytically-active mature natural killer (NK) cells (CD56dim); these cells are more plentiful in women than in men at ages greater than age 70 [37, 190] and these cells may participate in suppression of SARS-CoV-2 infection. Other possible mechanisms may too be involved in protection of women from COVID-19. SARS-CoV-2 may activate the ACE/AT1 axis by down-regulating ACE2 and thereby promoting the development of ARDS by inducing an inflammatory storm and increasing oxidative stress. 17β-estradiol may enhance expression levels of ACE2 (ACE2/Mas axis) and reduce ARDS. Activation of estrogen receptors regulates 17β-estradiol-mediated cellular signaling and gene expression. ACE catalyzes the conversion of Ang I to Ang II, which activates AT1 receptors. ACE2 catalyzes the conversion of Ang II to Ang I-7, which activates the Mas receptor. (SARS-CoV-2, severe acute respiratory syndrome-coronavirus 2; ER-α, estrogen receptor-α; ER-β, estrogen receptor-β; AT1R, angiotensin II type 1 (AT1) receptor; ACE, angiotensin-converting enzyme; ACE2, angiotensin-converting enzyme 2; MasR, Mas receptor; Ang II, angiotensin II; Ang 1-7, angiotensin 1-7). An outbreak of NCIP (2019-nCoV) infection in China-wuhan Emergence of a novel coronavirus causing respiratory illness from Wuhan Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan Spread of SARS-CoV-2 in the Icelandic Population SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitorslessons from available evidence and insights into COVID-19. Hypertension Research Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis Organspecific distribution of ACE2 mRNA and correlating peptidase activity in rodents SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure Angiotensin-converting enzyme 2: central regulator for cardiovascular function Angiotensin-converting enzyme 2: the first decade Recombinant human ACE2: acing out angiotensin II in ARDS therapy The renin-angiotensin system in acute respiratory distress syndrome Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist Activation of angiotensinconverting enzyme 2 (ACE2) attenuates allergic airway inflammation in rat asthma model ACE-2 Expression in the Small Airway Epithelia of Smokers and COPD Patients: Implications for COVID-19 Angiotensin-converting enzyme-2 overexpression attenuates inflammation in rat model of chronic obstructive pulmonary disease Local Renin-Angiotensin II Systems, Angiotensin-Converting Enzyme and its Homologue ACE2: Their Potential Role in the Pathogenesis of Chronic Obstructive Pulmonary Diseases, Pulmonary Hypertension and Acute Respiratory Distress Syndrome Angiotensin-converting enzyme 2 as a therapeutic target for heart failure Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection ACE2 and the Homolog Collectrin in the Modulation of Nitric Oxide and Oxidative Stress in Blood Pressure Homeostasis and Vascular Injury Angiotensin-converting enzyme 2 attenuates inflammatory response and oxidative stress in hyperoxic lung injury by regulating NF-κB and Nrf2 pathways Angiotensin I-Converting Enzyme Type 2 (ACE2) Gene Therapy Improves Glycemic Control in Diabetic Mice COVID-19, diabetes mellitus and ACE2: The conundrum 17β-Estradiol protects against the progression of hypertension during adulthood in a mouse model of systemic lupus erythematosus Vascular actions of estrogens: functional implications Effects of estrogen on the vascular system Estrogen Signaling and MicroRNAs in Lung Fibrosis. Sex, Hormones, and Rock Scars Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis Estrogen Signaling in Metabolic Inflammation The Complex Role of Estrogens in Inflammation Sexual maturation protects against development of lung inflammation through estrogen Estrogens and Autoimmune Diseases Sex Hormones in Acquired Immunity and Autoimmune Disease estrogen-like molecules and autoimmune diseases 17β-Estradiol inhibits HIV-1 by inducing a complex formation between β-catenin and estrogen receptor α on the HIV promoter to suppress HIV transcription Effects of 17beta-estradiol on the replication of rubella virus in an estrogen-responsive, continuous cell line 17,β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle Neuroprotective effects of estrogen in CNS injuries: insights from animal models Estrogen Receptor Alpha Inhibits the Estrogen-Mediated Suppression of HIV Transcription in Astrocytes: Implications for Estrogen Neuroprotection in HIV Dementia Neuroprotective Effects of Estrogen-New Insights into Mechanisms of Action Gender differences in COVID-19 infection. The estrogen effect on upper and lower airways. Can it help to figure out a treatment? 17≤-Estradiol, a potential ally to alleviate SARS-CoV-2 infection ACE2 expression and sex disparity in COVID-19 Estrogen shields women from COVID-19 complications by reducing ER stress Estrogen and COVID-19 symptoms: associations in women from the COVID Symptom Study An Update on the Tissue Renin Angiotensin System and Its Role in Physiology and Pathology The reninangiotensin system: going beyond the classical paradigms ACE2 as therapy for pulmonary arterial hypertension: the good outweighs the bad Annual Update in Intensive Care and Emergency Medicine Does ACE2 contribute to the development of hypertension? Hypertension Research ACE2/Angiotensin 1-7 protective anti-inflammatory and antioxidant role in hyperoxic lung injury: support from studies in Bartter's and Gitelman's syndromes Sex differences in vascular physiology and pathophysiology: estrogen and androgen signaling in health and disease Sex Hormones Promote Opposite Effects on ACE and ACE2 Activity, Hypertrophy and Cardiac Contractility in Spontaneously Hypertensive Rats Sex Differences in AT2R Expression and Action In: Unger T, Steckelings UM, dos Sex differences in the metabolic effects of the reninangiotensin system Sex Differences in Cardiovascular Pathophysiology Estradiol, acting through ERα, induces endothelial non-classic renin-angiotensin system increasing angiotensin 1-7 production Estrogen Regulation of Angiotensin-Converting Enzyme mRNA Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men Testosterone downregulates angiotensin II type-2 receptor via androgen receptor-mediated ERK1/2 MAP kinase pathway in rat aorta Testosterone plays a permissive role in angiotensin II-induced hypertension and cardiac hypertrophy in male rats Author manuscript; available in PMC Hypertension, RAS, and gender: what is the role of aminopeptidases? The endocrinology of the menopause The "his and hers" of the renin-angiotensin system Sex differences in the aging pattern of renin-angiotensin system serum peptidases Age-associated inflammation connects RAS-induced senescence to stem cell dysfunction and epidermal malignancy Effect of Age on the Development of ARDS in Trauma Patients ARDS in Aged Patients: Respiratory System Mechanics and Outcome Hypertension in the elderly The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs Redefining Chronic Inflammation in Aging and Age-Related Diseases: Proposal of the Senoinflammation Concept Wnt/β-catenin/RAS signaling mediates agerelated renal fibrosis and is associated with mitochondrial dysfunction Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63 Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63 ACE2 and pACE2: A Pair of Aces for Pulmonary Arterial Hypertension Treatment? Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1/2 and NF-κB signaling pathways The renin-angiotensin system from conception to old age: the good, the bad and the ugly ACE2 Over-Expression Protects Retinal Vascular Dysfunction in an Animal Model of Diabetic Retinopathy Overview of the immune response Immunity to viruses Sex differences in immune responses CD200 receptor controls sex-specific TLR7 responses to viral infection How sex and age affect immune responses, susceptibility to infections, and response to vaccination Sex chromosome complement contributes to sex differences in coxsackievirus B3 but not influenza A virus pathogenesis The Effect of Testosterone Replacement on Endogenous Inflammatory Cytokines and Lipid Profiles in Hypogonadal Men Pathogen recognition and inflammatory signaling in innate immune defenses Lung epithelial cells: therapeutically inducible effectors of antimicrobial defense Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1 17β-Estradiol Promotes TLR4-Triggered Proinflammatory Mediator Production through Direct Estrogen Receptor α Signaling in Macrophages In Vivo Immunomodulatory Effects of 17β-Estradiol on Epithelial Cells during Bacterial Infections Effects of estradiol on lipopolysaccharide and Pam3Cys stimulation of CCL20/macrophage inflammatory protein 3 alpha and tumor necrosis factor alpha production by uterine epithelial cells in culture Estradiol selectively regulates innate immune function by polarized human uterine epithelial cells in culture Regulation of innate immune function in bovine oviduct epithelial cells in culture: the homeostatic role of epithelial cells in balancing Th1/Th2 response Estrogen ameliorates allergic airway inflammation by regulating activation of NLRP3 in mice Estradiol Enhances CD4+ T-Cell Anti-Viral Immunity by Priming Vaginal DCs to Induce Th17 Responses via an IL-1-Dependent Pathway Estrogen accelerates the resolution of inflammation in macrophagic cells Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site Author manuscript; available in PMC The Immune System Is a Natural Target for Estrogen Action: Opposing Effects of Estrogen in Two Prototypical Autoimmune Diseases Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools The trinity of COVID-19: immunity, inflammation and intervention IL-6 in inflammation, immunity, and disease. Cold Spring Harbor Perspectives in Biology Effective treatment of severe COVID-19 patients with tocilizumab Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies Trials of antitumour necrosis factor therapy for COVID-19 are urgently needed Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta Estradiol repression of tumor necrosis factor-α transcription requires estrogen receptor activation function-2 and is enhanced by coactivators Estrogen Treatment Down-Regulates TNF-α Production and Reduces the Severity of Experimental Autoimmune Encephalomyelitis in Cytokine Knockout Mice Acute effects of estradiol on lung inflammation due to intestinal ischemic insult in male rats The influence of sex steroid hormones on the response to trauma and burn injury The complex ultrastructure of the endolysosomal system. Cold Spring Harbor Perspectives in Biology The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration Delivery of endocytosed membrane proteins to the lysosome BK channels regulate extracellular Tat-mediated HIV-1 LTR transactivation Role of endolysosomes and inter-organellar signaling in brain disease Involvement of organelles and inter-organellar signaling in the pathogenesis of HIV-1 associated neurocognitive disorder and Alzheimer's disease The Lysosome as a Regulatory Hub Processing for MHC Class II Presentation via Autophagy Two-pore channels regulate Tat endolysosome escape and Tat-mediated HIV-1 LTR transactivation Author manuscript; available in PMC Disorders of lysosomal acidification-The emerging role of v-ATPase in aging and neurodegenerative disease Dysfunction of autophagy and endosomallysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer's Disease Endo-lysosomal dysregulations and late-onset Alzheimer's disease: impact of genetic risk factors Importance of measuring endolysosome, cytosolic, and extracellular pH in understanding the pathogenesis of and possible treatments for glioblastoma multiforme How does estrogen work on autophagy? Essential role of Ca2+-dependent phospholipase A2 in estradiol-induced lysosome activation Testosterone regulates the autophagic clearance of androgen binding protein in rat Sertoli cells Testosterone increases apoptotic cell death and decreases mitophagy in Leber's hereditary optic neuropathy cells The effects of testosterone deprivation and supplementation on proteasomal and autophagy activity in the skeletal muscle of the male mouse: differential effects on high-androgen responder and low-androgen responder muscle groups Androgens modulate autophagy and cell death via regulation of the endoplasmic reticulum chaperone glucose-regulated protein 78/BiP in prostate cancer cells Gold nanoparticle uptake is enhanced by estradiol in MCF-7 breast cancer cells Estrogen negatively regulates the renal epithelial sodium channel (ENaC) by promoting Derlin-1 expression and AMPK activation AMPK: a balancer of the renin-angiotensin system AMPK Phosphorylation of ACE2 in Endothelium Mitigates Pulmonary Hypertension Estradiol activates AMPK through interaction with extrogen receptor beta (15.4) Oestrogen receptors interact with the α-catalytic subunit of AMP-activated protein kinase Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury Author manuscript; available in PMC Activation of AMPK attenuates LPSinduced acute lung injury by upregulation of PGC1α and SOD1. Experimental and Therapeutic Medicine The spike protein of SARS-CoV -A target for vaccine and therapeutic development HIV-1 infects macrophages by exploiting an endocytic route dependent on dynamin, Rac1 and Pak1 A pneumonia outbreak associated with a new coronavirus of probable bat origin ERβ promotes Aβ degradation via the modulation of autophagy Analysis of SARS-CoV-2-controlled autophagy reveals spermidine, MK-2206, and niclosamide as putative antiviral therapeutics Estrogenicity of soybeans (Glycine max) varies by plant organ and developmental stage Mammalian sex hormones in plants The effect of sex on immune cells in healthy aging: Elderly women have more robust natural killer lymphocytes than do elderly men I am thankful to Prof. Jonathan D. Geiger (University of North Dakota) for his on-going efforts on my behalf including intellectual support and the editing of this manuscript. This work was partly supported by NIH grant RO1 (MH119000). The virus infects the cell by binding spike proteins with ACE2 on cell membranes following priming by TMPRSS2. Following endolysosome escape, RNA can accumulate in the cytosol, where it participates in protein translation. Translated proteins produce a replication complex to make viral RNA. 17β-estradiol may enhance the endolysosome's degradation of the virus by enhancing the fusion of endosomes and lysosomes, probably by increasing AMPK activity and other possible mechanisms. Moreover, 17β-estradiol-mediated AMPK activation may enhance ACE2 stability by inducing phosphorylation and reduce ARDS and pulmonary hypertension. (SARS-CoV2: Severe Acute Respiratory Syndrome-Coronavirus 2; ACE2: Angiotensin-Converting Enzyme 2; p-ACE2: Phosphor-Angiotensin-Converting Enzyme 2; TMPRSS2: Transmembrane Protease, Serine 2; Ang II: Angiotensin II; Ang 1-7: Angiotensin 1-7; AMPKα: Adenosine Monophosphate Kinase-α; ER: Endoplasmic Reticulum). Khan Page 19J Allergy Infect Dis. Author manuscript; available in PMC 2020 November 13.